v3.25.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Federal grants $ 1,319,772 $ 305,722
Operating expenses:    
Research and development 1,885,528 778,904
General and administrative 1,401,756 1,369,782
Total operating expenses 3,287,284 2,148,686
Loss from operations (1,967,512) (1,842,964)
Other income (expense):    
Change in fair value of liability classified warrants 9,916 8,955
Interest expense, net (3,856) (1,248,065)
Other income and expense, net 15,879 (34,489)
Total other income (expense), net 21,939 (1,273,599)
Net loss (1,945,573) (3,116,563)
Net loss attributable to noncontrolling interests (74)
Deemed dividend related to warrants down round provision 290
Net loss attributable to common stockholders $ (1,945,573) $ (3,116,779)
Net loss per basic and diluted share:    
Net loss per share attributable to common stockholders, basic $ (1.39) $ (8.21)
Net loss per share attributable to common stockholders, diluted $ (1.39) $ (8.21)
Weighted average common shares outstanding, basic 1,401,144 379,634
Weighted average common shares outstanding, diluted 1,401,144 379,634

Source

PDF HTML
ZIP XLS XBRL